MICHELE PROVOST: Open Payments
NPI 1043388754 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 47 payments from 15 companies in 2025. Trend: 2023 $845 · 2024 $994 · 2025 $913
Food & beverage: $858Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $181 |
| Amgen Inc. | 9 | $168 |
| Novartis Pharmaceuticals Corporation | 10 | $164 |
| UCB, Inc. | 3 | $57 |
| PFIZER INC. | 2 | $55 |
| Janssen Biotech, Inc. | 1 | $55 |
| Fresenius Kabi USA, LLC | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Lilly USA, LLC | 1 | $32 |
Products named: COSENTYX, RINVOQ, OTEZLA, SKYRIZI, Bimzelx, XELJANZ, TREMFYA, EVENITY.
Industry payments across NC — which companies pay providers there.
